MRNA vs STE · rev $1.94B vs P/E 25, rev $5.46B
Moderna Inc (MRNA) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
MRNA currently screens at market cap $24.52B. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the MRNA and STE stock pages for the full models.
Not investment advice.